Gokhan Batur, new Chairman of the Board of Directors of Santero Therapeutics Gokhan Batur has been an independent director of Santero since January 2024. His proven ability to guide pharma businesses and biotechnology companies – from early-stage development through major comm...
Santero biotech opens up a new avenue for antibiotics L'Echo : La biotech Santero ouvre une nouvelle voie pour les antibiotiques lire l'article......
Walloon biotech fights antibiotic resistance Le Brief de L’Echo: Une biotech wallonne combat la résistance aux antibiotiques : Lire l'article......
What we have here is a discovery that could help solve a serious public health problem La Libre : Nous tenons là une découverte qui pourrait contribuer à résoudre un grave problème de santé publique Lire l'article......
What the press says about us Biovox: Antimicrobial resistance: How public and private investment is essential L'Echo: Santero raises funds to attack the “Achilles heel” of bacteria De Tijd: Santero strijdt met vers geld tegen 'ac...
Emilie Racine, new COO of Santero therapeutics We are delighted to welcome Émilie to the position of COO at Santero therapeutics , where she will bring her expertise to accelerate the development of new solutions against antimicrobial resistance, ...
See you at the AMR Conference! We are proud to announce that Santero therapeutics will be a speaker at the AMR Conference in Basel on February 25 and 26! On February 26 at 3.30pm, Cédric Govaerts co-founder of Santero therapeutics,...